Edition:
United Kingdom

People: Prothena Corporation PLC (PRTA.OQ)

PRTA.OQ on NASDAQ Stock Exchange Global Select Market

10.70USD
18 Apr 2019
Change (% chg)

$-0.06 (-0.56%)
Prev Close
$10.76
Open
$10.73
Day's High
$10.85
Day's Low
$10.43
Volume
96,522
Avg. Vol
135,727
52-wk High
$38.76
52-wk Low
$8.66

Nguyen, Tran 

Mr. Tran B. Nguyen is Chief Financial Officer, Chief Operating Officer of the Company. He has served as the Company’s Chief Financial Officer since 2013. Prior to joining the Company in 2013, he was Vice President, Chief Financial Officer (from 2010 to 2011) and then Senior Vice President, Chief Financial Officer of Somaxon Pharmaceuticals, Inc. (a biopharmaceutical company), from 2011 until its sale in 2013. Mr. Nguyen was Vice President, Chief Financial Officer at Metabasis Therapeutics, Inc. (a biopharmaceutical company) from 2009 until its sale in 2010. Mr. Nguyen serves on the board of directors of Sierra Oncology, Inc. (a publicly-traded clinical-stage oncology company) and Rain Therapeutics Inc. (a privately-held clinical-stage oncology company). He earned his BA in Economics and Psychology from Claremont McKenna College and his MBA from the Anderson School of Management at the University of California, Los Angeles.

Basic Compensation

Total Annual Compensation, USD 399,167
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,861,550
Fiscal Year Total, USD 3,260,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lars Ekman

526,938

Gene Kinney

5,148,240

Tran Nguyen

3,260,720

Karin Walker

--

Wagner Zago

--

Arthur Homan

2,479,620
As Of  31 Dec 2017